Search research articles
Contact Us
Filters
Showing results (521-530 of 618) with videos related to
Page
of 62
Sort By:
Rheumatology International
|
November 22, 2011
A profile of gout patients in Sarawak
C L Teh, Y K Cheong, H N Ling, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1989
The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man
A Masuda, T Shibasaki, Y S Kim, et al.
Biochemical and Biophysical Research Communications
|
December 16, 1987
Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid
K Sato, M Hotta, J Kageyama, et al.
Annual Review of Pharmacology and Toxicology
|
January 1, 1985
Physiological studies with somatocrinin, a growth hormone-releasing factor
W B Wehrenberg, A Baird, F Zeytin, et al.
Biochemical and Biophysical Research Communications
|
November 21, 1977
Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture
K W Kan, A Baird, N G Seidah, et al.
Biochemical and Biophysical Research Communications
|
July 18, 1984
Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1
N Ling, A Baird, W B Wehrenberg, et al.
Gynecologic Investigation
|
January 1, 1971
Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor
R Guillemin, M Amoss, R Blackwell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1984
Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts
T Shibasaki, Y Kiyosawa, A Masuda, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1982
Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens
J P Huidobro-Toro, E M Caturay, N Ling, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 1, 1985
A model system that predicts effective half-life for radiolabeled antibody therapy
J L Klein, M N Ling, P K Leichner, et al.
Page
of 62
Search research articles
Search
Showing results (521-530 of 618) with videos related to
Sort By:
Page
of 62
Rheumatology International
|
November 22, 2011
A profile of gout patients in Sarawak
C L Teh, Y K Cheong, H N Ling, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1989
The somatostatin analog octreotide inhibits the secretion of growth hormone (GH)-releasing hormone, thyrotropin, and GH in man
A Masuda, T Shibasaki, Y S Kim, et al.
Biochemical and Biophysical Research Communications
|
December 16, 1987
Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid
K Sato, M Hotta, J Kageyama, et al.
Annual Review of Pharmacology and Toxicology
|
January 1, 1985
Physiological studies with somatocrinin, a growth hormone-releasing factor
W B Wehrenberg, A Baird, F Zeytin, et al.
Biochemical and Biophysical Research Communications
|
November 21, 1977
Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture
K W Kan, A Baird, N G Seidah, et al.
Biochemical and Biophysical Research Communications
|
July 18, 1984
Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1
N Ling, A Baird, W B Wehrenberg, et al.
Gynecologic Investigation
|
January 1, 1971
Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor
R Guillemin, M Amoss, R Blackwell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1984
Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts
T Shibasaki, Y Kiyosawa, A Masuda, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1982
Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens
J P Huidobro-Toro, E M Caturay, N Ling, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 1, 1985
A model system that predicts effective half-life for radiolabeled antibody therapy
J L Klein, M N Ling, P K Leichner, et al.
Page
of 62